Generate Biomedicines machine learning biotech raises $273M

AdobeBiotechstartupGenerateBiomedicines,whichusesartificialintelligencetofindnewdrugs,raised$273mill SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We




leisure time

author：hotspot    Page View：1
Adam's take main illustration
Molly Ferguson/STAT

Biotech is awash in PIPEs.

The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

advertisement

Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： Why hospitals are withdrawing from US News rankings
Next article： Moonlake's readout produced a cash windfall. Risks remain